SHS sells shares of endoscope manufacturer Blazejewski MEDI-TECH GmbH to Erbe Group

Issuer: SHS Gesellschaft für Beteiligungsmanagement mbH / Keyword(s): Sale/Private Equity
28.10.2022 / 14:00 CET/CEST
The issuer is solely responsible for the content of this announcement.

Blazejewski MEDI-TECH CEO Reinhold Blazejewski

Blazejewski MEDI-TECH CEO Reinhold Blazejewski

  • Blazejewski MEDI-TECH GmbH is one of the technological leaders in the field of complex 2D and 3D endoscopy and has been able to develop very strongly in recent years.

  • Reinhold Blazejewski, founder and managing director of Blazejewski MEDI-TECH, also sells part of his shares to the Erbe group, but remains in the company as a minority shareholder and managing director.

  • SHS joined Blazejewski MEDI-TECH as a minority shareholder in early 2020 to support business and product portfolio growth

  • The Erbe Group develops, produces and distributes surgical products for clinics and specialist practices and is one of the co-founders of electrosurgery

Tubingen / October 28, 2022

The Tübingen-based healthcare investor SHS is selling its shares in the Baden-based endoscope developer and manufacturer Blazejewski MEDI-TECH GmbH to the Erbe Group.

The Tübingen-based investment company SHS acquired shares in the endoscope manufacturer in 2020 as part of a minority investment. The objective of the cooperation was to use the industrial know-how of SHS to develop other technologies and products and win new international customers and partners. This has happened successively in recent years. In this way, the company managed to expand its customer base, recruit more managers and employees, further develop chip-on-the-tip 2D and 3D technologies, and expand the production site. While Blazejewski MEDI-TECH was already one of the leading OEM manufacturers of endoscopes for medical technology before SHS’s investment, the company managed to grow further during SHS’s ownership period and expand its place as one of the technology leaders for complex rod lenses and 2D and 3D chip-on-the-tip endoscopy systems. With its exceptional competence, experience and position in electrosurgery and its excellent market access, the Erbe Group is now the ideal partner to help Blazejewski MEDI-TECH drive growth and bring new generations of endoscopy systems to market. Innovative 2D and 3D.

“Blazejewski MEDI-TECH GmbH has become the technology leader in the field of video endoscopy over the past 30 years. The Erbe Group is a worldwide technical leader in the field of energy procedures. The synergy resulting from the combination of these approaches opens up innovative perspectives approaches in the diagnosis and therapy of medical conditions. The goal is to create a “see and treat” procedure that allows the best possible therapeutic procedures and therefore the greatest possible benefit for the patient”, says Christian O. Erbe, CEO of the Erbe Group.

“We would like to thank SHS, who have supported us through their network and deep industry know-how. With SHS, we have found an investor who appreciates and respects the history of our individual company. Furthermore, we are delighted to have found the ideal partner for the next steps towards the successful future of the company with the Erbe Group as buyer, from which customers and employees will benefit”, explains Reinhold Blazejewski, CEO of Blazejewski.

“From the start, Blazejewski MEDI-TECH was an impressive example of a medium-sized German company with outstanding technologies and products and a strong team. We are delighted to have been able to support the company with our sector expertise in its future development. and growth. With the Erbe Group as the buyer, Blazejewski MEDI-TECH has found a truly ideal strategic partner. We wish them both the best for their future cooperation. Furthermore, we look forward to continuing to support the promising medical and healthcare technology companies in the SME sector on the road to success in the future,” says Manfred Ulmer-Weber, Managing Partner of SHS.

About SHS Gesellschaft für Beteiligungsmanagement mbH

“Building European Healthcare Champions” is the guiding principle of the Tübingen-based sector investor SHS. With this in mind, the investor specializing in healthcare investments finances and develops the companies in his portfolio. Since its inception in 1993, its investments have focused on financing expansion, shareholder changes and succession situations. In doing so, SHS takes both minority and majority stakes. Investors in SHS funds include pension funds, funds of funds, family offices, entrepreneurs, strategic investors and the SHS management team. The capital investment of the company registered with the AIFM amounts to 50 million euros. Greater volumes can be achieved with a network of co-investors. SHS places great importance on ethical considerations in its investment decisions and is therefore committed to following the guidelines of the UN PRI, an investor initiative launched by the United Nations Environment Programme. SHS has just launched its sixth fund.

More information at:

Would you like to receive regular updates on SHS? Subscribe to our newsletter
and follow us on LinkedIn

PR contact:
Sarah Stelzer
SHS Gesellschaft für Beteiligungsmanagement mbH
Bismarckstraße 12
72072 Tubingen
[email protected]

Broadcast of a Corporate News, transmitted by EQS News – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

EQS distribution services include regulatory announcements, financial/corporate news and press releases.
Archives on

Comments are closed.